sales@contrivedatuminsights.com
CDI - Contrive Datum Insights
Machinery & Construction

Solid Phase Extraction Spe Equipment MarketSize, Share & Industry Analysis, 2026-2034By TypeBy ApplicationBy TechnologyBy End UseBy Automation Level

Full title & scope — all 5 axes with their segments

Solid Phase Extraction Spe Equipment Market Size, Share & Industry Analysis, By Type (SPE Cartridges, SPE Disk, Well Plate), By Application (Chemical, Food, Biological, Others), By Technology (Reverse Phase, Normal Phase, Ion Exchange, Mixed Mode), By End Use (Pharmaceutical & Biotechnology Companies, Environmental Testing Laboratories, Food & Beverage Testing Laboratories, Forensic & Clinical Laboratories, Academic & Research Institutes), By Automation Level (Manual SPE Systems, Automated/Robotic SPE Systems), and Regional Forecast, 2026-2034

Last Updated: Sep 24, 2026Report ID: CDI-116026
Summary

Market outlook, key takeaways, drivers and challenges for the report period.

Historical period
2020-2024
Base year
2025
Forecast period
2026-2034
CAGR
7.95%
Market size trend
20202025 base year2034
Global market size
2025 · baseUSD 397 Million
2026USD 428 Million
2034 · forecastUSD 789 Million
Leading region, 2025
North America · 34%
Leading Region
North America leads with 33.6% of global revenue through 2034
Segmentation
  1. 01By TypeSPE Cartridges · SPE Disk · Well Plate
  2. 02By ApplicationChemical · Food · Biological
  3. 03By TechnologyReverse Phase · Normal Phase · Ion Exchange
  4. 04By End UsePharmaceutical & Biotechnology Companies · Environmental Testing Laboratories · Food & Beverage Testing Laboratories
  5. 05By Automation LevelManual SPE Systems · Automated/Robotic SPE Systems
  6. 06By Region
Overview

Market Analysis & Outlook

Solid phase extraction equipment covers the cartridges, extraction disks, well plates and associated manual and automated processing systems used to isolate, concentrate or clean up target analytes from a liquid sample ahead of chromatographic or spectrometric analysis. The category spans single-use consumable formats sized for individual sample runs through to multi-well plate formats designed for high-throughput, automated processing on robotic liquid-handling platforms. Buyers are laboratories that run quantitative chemical analysis as a core function: pharmaceutical and contract-testing labs preparing samples for bioanalytical assays, environmental and food-testing labs screening for regulated contaminants, and forensic and clinical toxicology labs processing casework and patient samples.

Growth of 7.95% a year carries the global solid phase extraction spe equipment market from USD 397 million in 2025 to USD 789 million in 2034. The full series behind that rate covers USD 265 million in 2020, USD 365 million in 2024, USD 428 million in 2026 and USD 581 million in 2030, with 2025 as the base year.

57.8% of 2025 revenue sits in SPE Cartridges, worth USD 229.5 million and rising to USD 410.3 million at 52% by 2034, the largest type line in both years. Growth is fastest in Well Plate at 10.68% and slowest in SPE Disk at 5.74%. The lines gaining share are Well Plate. SPE Cartridges and SPE Disk lose share without losing revenue.

By application, Biological accounts for 42% of 2025 revenue at USD 166.7 million, reaching USD 347.2 million and 44% by 2034. Food grows faster at 8.52% against 8.49%, moving from 20% of revenue to 21% by 2034. This axis divides the same revenue as the type split instead of adding to it, so the two are read together and never summed.

North America is the largest region at 33.6% of 2025 revenue, worth USD 133.4 million and reaching USD 244.5 million by 2034. Asia Pacific follows at 29.5%, moving from USD 117.1 million to USD 268.3 million, and Middle East and Africa is the smallest at 4.8%. Share shifts toward Asia Pacific and Latin America over the forecast period, so the regional split repays a close reading.

The 2025 total is arrived at by triangulating published aggregates against category proxies, not by an independent count. Segment, regional and country splits are estimated on the same basis, which bounds the precision of the figures above. Coverage runs to five regions, three type lines and five segmentation axes across a fifteen-year window.

Market Size, 20202034

USD Million
Base year 2025
USD 397 Million
Forecast 2034
USD 789 Million
CAGR 2025–2034
7.95%
ActualForecast
1,000
750
500
250
0
265
287
310
335
365
397
428
462
499
538
581
627
677
731
789
Forecast →
2020
2022
2024
2026
2028
2030
2032
2034

Revenue in USD Million. Values up to 2025 are actuals; 2026–2034 are forecast.

Analysis

Key Takeaways

  • The global solid phase extraction spe equipment market moves from USD 265 million in 2020 to USD 397 million in 2025 and USD 789 million by 2034, the forecast period compounding at 7.95% a year.
  • The largest line by type is SPE Cartridges, worth USD 229.5 million and 57.8% of revenue in 2025, rising to USD 410.3 million and 52% by 2034.
  • At 10.68%, Well Plate grows faster than any other type line, moving from USD 120.3 million and 30.3% of revenue in 2025 to USD 299.8 million and 38% in 2034.
  • Against a base case of USD 789 million in 2034, the study also reports a bear case at USD 710.1 million and a bull case at USD 883.7 million, with the assumptions behind each set out separately.
  • The largest region is North America, generating USD 133.4 million in 2025 (33.6% of the global total) and USD 244.5 million by 2034, ahead of Asia Pacific at 29.5%.
  • The United States accounts for 85% of North America in the base year, worth USD 113.4 million in 2025 and reaching USD 207.8 million by 2034, the worked country example carried through that region's chapters.
  • Every line on all five segmentation axes and in each of the five regions carries its own revenue, share and growth rate for all fifteen years, 2020 through 2034, on a 2025 base.
Analysis

Revenue Share, By By Type

Base year 2025

SPE Cartridges leads with 57.8% of by type segment revenue.

58%
SPE Cartridges
SPE Cartridges
57.8%
Well Plate
30.3%
SPE Disk
11.9%

Share of by type segment revenue, most recent base year.

Three things move over 2026-2034, and they are worth separating: the type mix, the regional balance, and the 7.95% compounding underneath both.

Not one of them points downward. Growth is everywhere in absolute terms, and the interest is entirely in where it lands.

Well Plate outpaces SPE Disk. The widest spread on the type axis is between Well Plate at 10.68% and SPE Disk at 5.74%. Over the forecast period that moves Well Plate from 30.3% of revenue to 38%, and SPE Disk from 11.9% to 10%. In absolute terms Well Plate rises from USD 120.3 million to USD 299.8 million, while SPE Disk rises from USD 47.2 million to USD 78.9 million. Both grow; the gap is wide enough to reshape the mix inside a single forecast window.

The regional balance moves. Asia Pacific moves from 29.5% of revenue in 2025 to 34% in 2034, worth USD 117.1 million rising to USD 268.3 million; Latin America moves from 5.2% of revenue in 2025 to 5.5% in 2034, worth USD 20.6 million rising to USD 43.4 million. The offsetting side is North America at 33.6% moving to 31%, Europe at 26.9% moving to 25%, Middle East and Africa at 4.8% moving to 4.5%, none of which contracts. The practical consequence is that regional weighting decides whether a participant matches the market rate or trails it, regardless of how its own revenue reads.

A continuation, not an inflection. The market moves through USD 265 million in 2020, USD 365 million in 2024, USD 397 million in 2025, USD 428 million in 2026, USD 581 million in 2030 and USD 789 million in 2034. Against 8.42% through the historical period, the 7.95% forecast rate is a continuation; no year in the series interrupts it. That moves the planning question away from timing a turn and onto the type and regional mixes, where the actual movement is.

Analysis

Market Growth Factors

Well Plate carries the market's growth rate

Market Drivers

3
  • 01
    Well Plate carries the market's growth rate

    Well Plate compounds at 10.68% against 7.95% for the market, rising from USD 120.3 million in 2025 to USD 299.8 million in 2034 and from 30.3% of revenue to 38%. Set against 5.74% at the other end of the axis, this is the line that decides whether the market's 7.95% holds. Where a supplier sits on this axis therefore decides whether it grows with the market or below it.

  • 02
    The two largest regions hold most of the base

    North America is the largest region at USD 133.4 million in 2025, 33.6% of global revenue, and reaches USD 244.5 million by 2034 while holding 31%. Asia Pacific adds a further 29.5% at USD 117.1 million, reaching USD 268.3 million. Most of the base and most of the growth sit in those two, and a plan spread evenly across regions therefore over-invests outside them.

  • 03
    A demonstrated trajectory, not a projected turnaround

    Revenue rose through USD 265 million in 2020, USD 365 million in 2024 and USD 397 million in 2025, a compound 8.42% across the historical period. From there the forecast carries 7.95% through to USD 789 million in 2034. A forecast extending an observed trend is a different proposition from one proposing a turn, and that is why no ramp is applied: the 7.95% runs evenly across the period.

Growth drivers

#Growth driverImpactGross contribution (Million)2026-282029-312032-34
1Rising bioanalytical and clinical testing demandHigh+165HighHighHigh
2Tightening environmental and food-safety testing regulationHigh+130HighHighMedium
3Adoption of automated, high-throughput SPE systemsMedium-High+75MediumHighHigh
4Growth in forensic and clinical toxicology testing capacityMedium+45MediumMediumMedium
5OthersLow+12LowLowLow
Total+427

Restraints

#RestraintImpactEstimated reduction (Million)2026-282029-312032-34
1Competition from alternative extraction techniquesMedium-High−25MediumMediumLow
2Budget constraints in academic and public-sector laboratoriesMedium−10MediumMediumMedium
Total−35

Drivers contribute 427 Million and restraints remove 35 Million, a net 392 Million, which is the revenue the market adds between the base year and 2034. Contributions are CDI estimates, apportioned so that they reconcile with the forecast rather than being read from it.

The 7.95% forecast rate rests on three things that can be measured separately: the size of the existing base, the mix shift on the type axis, and where regional growth is concentrated.

Analysis

Restraining Factors

What holds the forecast back

Market Restraints

2
  • 01
    What holds the forecast back

    Automation adoption slows as laboratories delay capital purchases, and a material loosening of residue-screening requirements in a large testing market or gains by alternative extraction techniques such as QuEChERS pull volume away from SPE cartridges and plates faster than the base case assumes. On that assumption 2034 revenue lands at USD 710.1 million against the USD 789 million base case, from the same USD 397 million 2025 starting point.

  • 02
    SPE Cartridges holds the blended rate down

    SPE Cartridges carries 57.8% of 2025 revenue at USD 229.5 million but compounds at 6.69% against 7.95% for the market, taking its share to 52% by 2034 even as revenue rises to USD 410.3 million. Because it carries that much of the base, its pace holds the blended rate down more than any faster line lifts it.

Analysis

Market Opportunities

What the bull case turns on

Market Opportunities

2
  • 01
    What the bull case turns on

    What would beat the forecast: automation adoption in high-throughput bioanalytical and contract-testing laboratories accelerates faster than the base case assumes, and residue-screening mandates in food and environmental testing expand into additional analyte panels sooner than currently scheduled. That case reaches USD 883.7 million in 2034 against USD 789 million, and it is worth testing against a reader's own read of the market.

  • 02
    Well Plate is where share changes hands

    Share on the type axis moves toward Well Plate, from 30.3% in 2025 to 38% in 2034, on 10.68% growth against the market's 7.95% and revenue rising from USD 120.3 million to USD 299.8 million. Taking position there does not require displacing whoever holds SPE Cartridges, which is the harder and more expensive fight.

Analysis

Market Challenges

Concentration on the type axis

Market Challenges

2
  • 01
    Concentration on the type axis

    One line dominates: SPE Cartridges, at 57.8% of revenue in 2025 and 52% in 2034, worth USD 229.5 million and USD 410.3 million. No other single change on the type axis moves the total as much as a change in demand for that one line.

  • 02
    The United States is 85% of North America

    North America is worth USD 133.4 million in 2025 and USD 113.4 million of that is the United States; 85% of the region, reaching USD 207.8 million in 2034. The consequence is that regional risk here is really country risk wearing a larger label.

Structure

Segmentation Analysis

5 axes

The market is divided by type and by application, technology, end use and automation level; five axes in all. They are alternative readings of one revenue pool, not parts that sum to it.

Three type lines are reported. One of them takes share over the forecast period and the rest give it up, though every line grows in absolute terms between 2025 and 2034.

By Type · 3 segments

Well Plate Outpaces the Axis While SPE Cartridges Holds the Largest Share

  • Largest SPE Cartridges · 57.8%
  • Fastest Well Plate · 10.7%
  • Moves most Well Plate · +7.7 pts
  • Order by 2034 unchanged
Segment2025Share2034ShareCAGR
SPE Cartridges$230M57.8%$410M52%-5.86.7%
SPE Disk$47.20M11.9%$78.90M10%-1.95.7%
Well Plate$120M30.3%$300M38%+7.710.7%
SPE Cartridges 52%SPE Disk 10%Well Plate 38%

SPE cartridges lead because they are the simplest, lowest-cost format and remain the default choice for single-sample manual extraction across most testing laboratories. Well plates are the fastest-growing format as laboratories adopt automated, high-throughput sample preparation to keep pace with LC-MS/MS testing volume. Disks remain the smallest format, used mainly for large-volume environmental water samples where a cartridge bed would clog. SPE Cartridges remains the largest line through 2034, so the axis changes in proportion, not in order. Every year of the series is priced on this axis, making it the reference cut for the rest of the report.

By Application · 4 segments

Scale in Biological and Growth in Food Define the Application Axis

  • Largest Biological · 42%
  • Fastest Food · 8.5%
  • Moves most Chemical · -2 pts
  • Order by 2034 unchanged
Segment2025Share2034ShareCAGR
Chemical$111M28%$205M26%-27%
Food$79.40M20%$166M21%+18.5%
Biological$167M42%$347M44%+28.5%
Others$39.70M10%$71M9%-16.7%
Chemical 26%Food 21%Biological 44%Others 9%

Biological applications lead because pharmaceutical, clinical and contract-testing laboratories run the highest volume of bioanalytical sample preparation of any buyer group. Food applications grow fastest as residue and contaminant screening mandates expand testing panels across more food categories. Chemical and industrial applications grow more slowly, reflecting a more mature, already well-served testing base. Biological remains the largest line through 2034, so the axis changes in proportion, not in order.

By Technology · 4 segments

Mixed Mode Outpaces the Axis While Reverse Phase Holds the Largest Share

  • Largest Reverse Phase · 45%
  • Fastest Mixed Mode · 10.4%
  • Moves most Mixed Mode · +5 pts
  • Order by 2034 unchanged
Segment2025Share2034ShareCAGR
Reverse Phase$179M45%$331M42%-37.1%
Normal Phase$51.60M13%$86.80M11%-26%
Ion Exchange$79.40M20%$158M20%7.9%
Mixed Mode$87.30M22%$213M27%+510.4%
Reverse Phase 42%Normal Phase 11%Ion Exchange 20%Mixed Mode 27%

Reverse-phase chemistry leads because it retains the broadest range of analyte polarities and is the default first choice for method developers across most sample types. Mixed-mode chemistry grows fastest as laboratories adopt it for complex biological matrices where a single retention mechanism cannot achieve adequate selectivity. Normal-phase chemistry grows slowest, limited to a narrower set of non-polar applications. The order does not change: Reverse Phase is still largest in 2034, and what moves is how much it holds.

By End Use · 5 segments

Pharmaceutical & Biotechnology Companies Led by End use in 2025, with Food & Beverage Testing Laboratories Growing Fastest

  • Largest Pharmaceutical & Biotechnology Companies · 38%
  • Fastest Food & Beverage Testing Laboratories · 8.8%
  • Moves most Pharmaceutical & Biotechnology Companies · +2 pts
  • Order by 2034 unchanged
Segment2025Share2034ShareCAGR
Pharmaceutical & Biotechnology Companies$151M38%$316M40%+28.6%
Environmental Testing Laboratories$87.30M22%$158M20%-26.8%
Food & Beverage Testing Laboratories$55.60M14%$118M15%+18.8%
Forensic & Clinical Laboratories$71.50M18%$150M19%+18.6%
Academic & Research Institutes$31.80M8%$47.30M6%-24.5%
Pharmaceutical & Biotechnology Companies 40%Environmental Testing Laboratories 20%Food & Beverage Testing Laboratories 15%Forensic & Clinical Laboratories 19%Academic & Research Institutes 6%

Pharmaceutical and biotechnology buyers lead because drug development and quality-control testing generate the highest and most consistent extraction volume of any end-use group. Food and beverage testing laboratories grow fastest as residue-screening mandates broaden. Academic and research institutes grow slowest, constrained by budget cycles that limit how quickly instrument and consumable purchasing can scale. Pharmaceutical & Biotechnology Companies remains the largest line through 2034, so the axis changes in proportion, not in order.

By Automation Level · 2 segments

Scale in Manual SPE Systems and Growth in Automated/Robotic SPE Systems Define the Automation level Axis

  • Largest Manual SPE Systems · 62%
  • Fastest Automated/Robotic SPE Systems · 10.8%
  • Moves most Manual SPE Systems · -10 pts
  • Order by 2034 unchanged
Segment2025Share2034ShareCAGR
Manual SPE Systems$246M62%$410M52%-105.8%
Automated/Robotic SPE Systems$151M38%$379M48%+1010.8%
Manual SPE Systems 52%Automated/Robotic SPE Systems 48%

Manual systems lead because they remain the lowest-cost entry point and suit laboratories running lower or variable sample volumes. Automated and robotic systems grow fastest as high-throughput laboratories prioritize consistency and labor reduction over the lower upfront cost of manual processing, a shift already underway in the largest contract-testing and pharmaceutical laboratories. By 2034 Manual SPE Systems is still ahead, making this a shift in weight, not a change of leader.

Analysis

Regional Insights

Regional Revenue Share

Base year 2025
34%
North America
Leading region
34%North America

Share of global revenue in the base year.

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Only the leading region's share is published outside the report; pins mark the region, not a specific country.

Leading Region
North America leads with 33.6% of global revenue through 2034

North America Market Analysis

The largest region covered — 2.6 points of share move elsewhere by 2034, while revenue still grows 1.8×.

  • Rank 1 of 5
  • 2025 share 33.6%
  • By 2034 31%
  • Revenue $133M → $245M

33.6% of the global solid phase extraction spe equipment market sits in North America in 2025, worth USD 133.4 million rising to USD 244.5 million in 2034. Among the five regions it ranks first by revenue in both years.

By 2034 the share stands at 31%, while nothing contracts here; other regions simply grow faster, which shows up as relative weight, not as falling revenue.

The type mix reported at global level applies here, with SPE Cartridges the largest line at 57.8% of 2025 revenue and Well Plate the fastest-growing at 10.68%. Revenue for North America is broken out by every segmentation axis and by country in the full report.

United States

Sets the pace for North America at 85% of it, growing 1.8×.

  • In region 1 of 2
  • Of region 85%
  • Of global 28.6%
  • Revenue $113M → $208M

85% of North America's base-year revenue comes from the United States; USD 113.4 million, rising to USD 207.8 million by 2034. 85% of the region in 2025 means the regional figures are, in practice, a view of this market with others attached. Against regional totals of USD 133.4 million in 2025 and USD 244.5 million in 2034, it is the country the full report breaks out in detail.

the United States buys along the same lines as the market globally; SPE Cartridges first at 57.8% of 2025 revenue and 52% in 2034, Well Plate fastest at 10.68% on a share moving from 30.3% to 38%. Since 85% of North America's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. The United States carries its own type breakdown in the full report.

Solid phase extraction equipment sold in the United States is treated as general laboratory apparatus rather than a medical device, so it falls outside direct Food and Drug Administration premarket clearance unless a manufacturer bundles it into a diagnostic workflow that itself needs authorization. Suppliers instead work within voluntary consensus standards from ASTM International and, where extraction cartridges or manifolds touch environmental or food-safety testing, methods recognized by the Environmental Protection Agency. Where the equipment supports clinical or forensic toxicology testing, laboratories using it must operate under Clinical Laboratory Improvement Amendments oversight, which places the compliance burden on the testing laboratory rather than the instrument maker. Electrical safety and electromagnetic compatibility conformity, typically demonstrated through Underwriters Laboratories or equivalent certification, is expected before equipment enters commercial laboratories, and accurate performance labelling is required to avoid misbranding under general Federal Trade Commission advertising rules.

Competition in the United States runs between the suppliers this study tracks: Thermo Fisher Scientific, Avantor Performance Materials, Waters Corporation, Agilent Technologies, S*Pure Pte Ltd, Merck, Biotage, PerkinElmer, 3M, GL Sciences, Restek Corporation, Orochem Technologies, Tecan SP and ANPEL Laboratory Technologies. SPE Cartridges, at 57.8% of 2025 revenue, is where the volume sits, and Well Plate, growing at 10.68%, is where position changes hands over the forecast period. Per-company positioning and share at country level are in the full report only.

Canada

2nd-largest in North America, growing 1.8×.

  • In region 2 of 2
  • Of region 15%
  • Of global 5%
  • Revenue $20M → $36.70M

Within North America, Canada accounts for 15% of regional revenue and 5% of the global total, worth USD 20 million in 2025 and USD 36.7 million by 2034.

Europe Market Analysis

The 3rd-largest region covered — 1.9 points of share move elsewhere by 2034, while revenue still grows 1.8×.

  • Rank 3 of 5
  • 2025 share 26.9%
  • By 2034 25%
  • Revenue $107M → $197M

USD 106.8 million of 2025 revenue is generated in Europe, 26.9% of the global solid phase extraction spe equipment market on the way to USD 197.3 million by 2034. Among the five regions it ranks third by revenue in both years.

Its share moves to 25% by 2034, a shift in share, not in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.

The type mix reported at global level applies here, with SPE Cartridges the largest line at 57.8% of 2025 revenue and Well Plate the fastest-growing at 10.68%. The full report breaks Europe out along every axis and by country.

Germany

The largest market in Europe, growing 1.8×.

  • In region 1 of 3
  • Of region 34%
  • Of global 9.1%
  • Revenue $36.30M → $67.10M

USD 36.3 million of Europe's 2025 revenue is generated in Germany, the region's largest market, reaching USD 67.1 million by 2034. Its 34% of base-year regional revenue leads the region, though enough sits elsewhere that Europe is not a proxy for it. Set against USD 106.8 million and USD 197.3 million for the region, it is why this market, and not a smaller one, is the one reported in full.

The type pattern in Germany is the global one: 57.8% of 2025 revenue in SPE Cartridges, 52% by 2034, against 10.68% growth in Well Plate taking it from 30.3% to 38%. Because the country carries 34% of Europe, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Revenue by type for Germany is reported separately in the full report.

In Germany, solid phase extraction systems are classified as laboratory equipment under the European Union's general product safety and machinery frameworks rather than as medical devices, so CE marking against the Machinery Regulation and, where applicable, the Low Voltage Directive and Electromagnetic Compatibility Directive governs market entry. Manufacturers must draw up a technical file, issue a declaration of conformity, and affix CE marking before sale, with the Bundesanstalt für Arbeitsschutz und Arbeitsmedizin overseeing workplace and equipment safety enforcement domestically. Where extraction equipment is deployed within accredited testing laboratories, conformity to relevant DIN and harmonized European standards for laboratory apparatus is expected as a condition of accreditation by the national accreditation body, DAkkS. Labelling must clearly state intended use, electrical ratings, and any hazard warnings in German, consistent with general EU product labelling obligations.

Competition in Germany runs between the suppliers this study tracks: Thermo Fisher Scientific, Avantor Performance Materials, Waters Corporation, Agilent Technologies, S*Pure Pte Ltd, Merck, Biotage, PerkinElmer, 3M, GL Sciences, Restek Corporation, Orochem Technologies, Tecan SP and ANPEL Laboratory Technologies. Volume sits in SPE Cartridges at 57.8% of 2025 revenue; movement sits in Well Plate at 10.68% growth. That makes Europe a 26.9% share of 2025 global revenue, USD 106.8 million rising to USD 197.3 million, for any supplier deciding where to concentrate.

United Kingdom

2nd-largest in Europe, growing 1.9×.

  • In region 2 of 3
  • Of region 27%
  • Of global 7.3%
  • Revenue $28.80M → $53.30M

The United Kingdom is sized at USD 28.8 million in 2025, rising to USD 53.3 million by 2034; 7.3% of global revenue and 27% of Europe. It is reported separately from Germany across every segmentation axis in the full report.

France

3rd-largest in Europe, growing 1.8×.

  • In region 3 of 3
  • Of region 20%
  • Of global 5.4%
  • Revenue $21.40M → $39.50M

Within Europe, France accounts for 20% of regional revenue and 5.4% of the global total, worth USD 21.4 million in 2025 and USD 39.5 million by 2034.

Asia Pacific Market Analysis

The 2nd-largest region covered, and the one gaining the most — it picks up 4.5 points of share by 2034, while revenue still grows 2.3×.

  • Rank 2 of 5
  • 2025 share 29.5%
  • By 2034 34%
  • Revenue $117M → $268M

29.5% of the global solid phase extraction spe equipment market sits in Asia Pacific in 2025, worth USD 117.1 million and reaches USD 268.3 million by 2034. That makes it the second-largest region covered, in 2025 and again in 2034.

34% of global revenue sits here by 2034, up from the 2025 level, at a pace above the 7.95% global rate, so this region warrants separate treatment and should not be scaled off the total.

Within the region the type split tracks the global one; 57.8% of 2025 revenue in SPE Cartridges, fastest growth of 10.68% in Well Plate. The full report breaks Asia Pacific out along every axis and by country.

China

The largest market in Asia Pacific, growing 2.4×.

  • In region 1 of 3
  • Of region 40%
  • Of global 11.8%
  • Revenue $46.80M → $110M

The largest single market in Asia Pacific is China, at USD 46.8 million in 2025 and USD 110 million in 2034. It accounts for 40% of regional revenue in the base year, the largest single share without dominating the region outright. Against regional totals of USD 117.1 million in 2025 and USD 268.3 million in 2034, it is the country the full report breaks out in detail.

China buys along the same lines as the market globally; SPE Cartridges first at 57.8% of 2025 revenue and 52% in 2034, Well Plate fastest at 10.68% on a share moving from 30.3% to 38%. With 40% of Asia Pacific concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. Per-type revenue for China appears on its own in the full report.

Solid phase extraction equipment is regulated in China as general scientific and laboratory instrumentation under the State Administration for Market Regulation rather than as a medical device, so it does not require National Medical Products Administration registration unless integrated into a registered diagnostic system. Compliance instead centres on Compulsory Product Certification, commonly known as CCC certification, for electrical safety where the equipment falls within scope, alongside conformity to relevant national GB standards covering laboratory apparatus performance and safety. Import and customs clearance require accurate technical documentation and labelling in Chinese identifying manufacturer, intended use, and electrical specifications. Laboratories using the equipment for environmental, food, or pharmaceutical testing must additionally follow method and quality requirements set by sector regulators such as the Ministry of Ecology and Environment or the National Institutes for Food and Drug Control, which govern the testing process rather than the extraction hardware itself.

In China the field is Thermo Fisher Scientific, Avantor Performance Materials, Waters Corporation, Agilent Technologies, S*Pure Pte Ltd, Merck, Biotage, PerkinElmer, 3M, GL Sciences, Restek Corporation, Orochem Technologies, Tecan SP and ANPEL Laboratory Technologies. The commercially relevant division is 57.8% of 2025 revenue in SPE Cartridges, where the volume is, against 10.68% growth in Well Plate, where share moves. That makes Asia Pacific a 29.5% share of 2025 global revenue, USD 117.1 million rising to USD 268.3 million, for any supplier deciding where to concentrate.

Japan

2nd-largest in Asia Pacific, growing 2.2×.

  • In region 2 of 3
  • Of region 22%
  • Of global 6.5%
  • Revenue $25.80M → $56.30M

Japan is sized at USD 25.8 million in 2025, rising to USD 56.3 million by 2034; 6.5% of global revenue and 22% of Asia Pacific. It is reported separately from China across every segmentation axis in the full report.

India

3rd-largest in Asia Pacific, growing 2.6×.

  • In region 3 of 3
  • Of region 15%
  • Of global 4.4%
  • Revenue $17.60M → $45.60M

India is sized at USD 17.6 million in 2025, rising to USD 45.6 million by 2034; 4.4% of global revenue and 15% of Asia Pacific. It is reported separately from China across every segmentation axis in the full report.

Latin America Market Analysis

The 4th-largest region covered — it picks up 0.3 points of share by 2034, while revenue still grows 2.1×.

  • Rank 4 of 5
  • 2025 share 5.2%
  • By 2034 5.5%
  • Revenue $20.60M → $43.40M

Latin America holds 5.2% of the global solid phase extraction spe equipment market in 2025, worth USD 20.6 million rising to USD 43.4 million in 2034. By revenue it sits fourth across the study, and the ranking does not change between 2025 and 2034.

Share climbs to 5.5% by 2034, on growth above the market's own 7.95%, and with a bigger contribution to the revenue added over the period than the base-year figure suggests.

Within the region the type split tracks the global one; 57.8% of 2025 revenue in SPE Cartridges, fastest growth of 10.68% in Well Plate. Per-axis and per-country detail for Latin America sits in the full report.

Brazil

The largest market in Latin America, growing 2.1×.

  • In region 1 of 2
  • Of region 54.9%
  • Of global 2.8%
  • Revenue $11.30M → $23.90M

Brazil is the largest market within Latin America, generating USD 11.3 million in 2025 and projected to reach USD 23.9 million by 2034. At 54.9% of the region in 2025 it leads, but a majority of Latin America's revenue is generated in other markets. The region itself runs USD 20.6 million to USD 43.4 million over the same period, and this is the market carrying the country-level detail in the full report.

Composition here matches the global split: the largest line is SPE Cartridges at 57.8% of 2025 revenue, easing to 52% by 2034, and the fastest is Well Plate at 10.68%, from 30.3% to 38%. Its 54.9% weight in Latin America means those movements carry straight into the regional totals. Revenue by type for Brazil is reported separately in the full report.

Brazil regulates solid phase extraction equipment as general laboratory instrumentation rather than as a medical device, placing it outside the direct registration authority of Agência Nacional de Vigilância Sanitária unless it forms part of an in vitro diagnostic system that itself requires ANVISA approval. Electrical and safety conformity is instead assessed under the National Institute of Metrology, Quality and Technology, whose certification scheme covers relevant laboratory equipment for electrical safety and metrological reliability before commercial distribution. Import documentation must include accurate Portuguese-language labelling describing intended use, manufacturer details, and safety warnings, consistent with general consumer and industrial product rules enforced by Brazil's consumer protection authorities. Laboratories applying the equipment within accredited testing environments must additionally meet quality standards set by the national accreditation body, Coordenação Geral de Acreditação, as a condition of maintaining accreditation.

Thermo Fisher Scientific, Avantor Performance Materials, Waters Corporation, Agilent Technologies, S*Pure Pte Ltd, Merck, Biotage, PerkinElmer, 3M, GL Sciences, Restek Corporation, Orochem Technologies, Tecan SP and ANPEL Laboratory Technologies are the suppliers covered in Brazil. Volume sits in SPE Cartridges at 57.8% of 2025 revenue; movement sits in Well Plate at 10.68% growth. The commercial size of that position is USD 20.6 million in 2025 and USD 43.4 million by 2034, 5.2% of the global total in the base year.

Mexico

2nd-largest in Latin America, growing 2.1×.

  • In region 2 of 2
  • Of region 30.1%
  • Of global 1.6%
  • Revenue $6.20M → $13M

Mexico is sized at USD 6.2 million in 2025, rising to USD 13 million by 2034; 1.6% of global revenue and 30.1% of Latin America. It is reported separately from Brazil across every segmentation axis in the full report.

Middle East and Africa Market Analysis

The 5th-largest region covered — 0.3 points of share move elsewhere by 2034, while revenue still grows 1.9×.

  • Rank 5 of 5
  • 2025 share 4.8%
  • By 2034 4.5%
  • Revenue $19.10M → $35.50M

USD 19.1 million of 2025 revenue is generated in Middle East and Africa, 4.8% of the global solid phase extraction spe equipment market on the way to USD 35.5 million by 2034. Among the five regions it ranks fifth by revenue in both years.

Its share moves to 4.5% by 2034, a shift in share, not in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.

Within the region the type split tracks the global one; 57.8% of 2025 revenue in SPE Cartridges, fastest growth of 10.68% in Well Plate. Middle East and Africa is reported axis by axis and country by country in the full study.

Saudi Arabia

The largest market in Middle East and Africa, growing 1.9×.

  • In region 1 of 2
  • Of region 35.1%
  • Of global 1.7%
  • Revenue $6.70M → $12.40M

The largest single market in Middle East and Africa is Saudi Arabia, at USD 6.7 million in 2025 and USD 12.4 million in 2034. It accounts for 35.1% of regional revenue in the base year, the largest single share without dominating the region outright. Against regional totals of USD 19.1 million in 2025 and USD 35.5 million in 2034, it is the country the full report breaks out in detail.

The type pattern in Saudi Arabia is the global one: 57.8% of 2025 revenue in SPE Cartridges, 52% by 2034, against 10.68% growth in Well Plate taking it from 30.3% to 38%. Because the country carries 35.1% of Middle East and Africa, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Per-type revenue for Saudi Arabia appears on its own in the full report.

In Saudi Arabia, solid phase extraction equipment is treated as general laboratory apparatus and is regulated primarily through the Saudi Standards, Metrology and Quality Organization, which sets conformity requirements for imported laboratory and scientific instruments and administers the Saudi Product Safety Program covering electrical and safety compliance. Where such equipment supports testing tied to pharmaceuticals, food, or clinical diagnostics, the Saudi Food and Drug Authority sets requirements for the testing methods and any diagnostic systems the equipment feeds into, though the extraction hardware itself is not separately registered as a medical device. Importers must provide a certificate of conformity and accurate Arabic-language labelling identifying manufacturer, intended use, and safety information before customs clearance. Laboratories operating under Gulf Cooperation Council accreditation frameworks are additionally expected to demonstrate that equipment used in accredited test methods meets applicable regional and international laboratory standards.

In Saudi Arabia the field is Thermo Fisher Scientific, Avantor Performance Materials, Waters Corporation, Agilent Technologies, S*Pure Pte Ltd, Merck, Biotage, PerkinElmer, 3M, GL Sciences, Restek Corporation, Orochem Technologies, Tecan SP and ANPEL Laboratory Technologies. SPE Cartridges, at 57.8% of 2025 revenue, is where the volume sits, and Well Plate, growing at 10.68%, is where position changes hands over the forecast period. The commercial size of that position is USD 19.1 million in 2025 and USD 35.5 million by 2034, 4.8% of the global total in the base year.

South Africa

2nd-largest in Middle East and Africa, growing 1.9×.

  • In region 2 of 2
  • Of region 29.8%
  • Of global 1.4%
  • Revenue $5.70M → $10.70M

1.4% of global revenue is generated in South Africa; USD 5.7 million in 2025, reaching USD 10.7 million in 2034, and 29.8% of Middle East and Africa.

Request this sample to see the full data tables and segment-level detail behind this analysis.

Analysis

Report Coverage

This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by Type, Application, Technology, End Use, Automation Level, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.

Competition

Competitive Landscape

Suppliers Compete on SPE Cartridges Volume and Well Plate Momentum

The field covered here is Thermo Fisher Scientific, Avantor Performance Materials, Waters Corporation, Agilent Technologies, S*Pure Pte Ltd, Merck, Biotage, PerkinElmer, 3M, GL Sciences, Restek Corporation, Orochem Technologies, Tecan SP and ANPEL Laboratory Technologies.

The type axis, not the regional one, is where competition happens. Volume sits in SPE Cartridges, USD 229.5 million and 57.8% of 2025 revenue, 52% by 2034, which is also where an incumbent is hardest to dislodge. Well Plate, compounding at 10.68% against 5.74% for SPE Disk, is where share changes hands over the forecast period. Holding the first and taking the second are separate capabilities, which is why a market of USD 397 million supports as many suppliers as it does.

Scale in manufacturing and formulation chemistry separates the largest suppliers from the rest: consistent cartridge bed-mass and plate-well uniformity across production lots matters more to a regulated testing lab than price, and only the largest manufacturers sustain that consistency at volume. Regulatory and validation experience is a second edge; a supplier that documents extraction recovery data against major method-validation guidelines qualifies into pharmaceutical and contract-testing labs faster. Distribution and channel reach decide who wins the smaller academic and regional labs, where a local distributor relationship matters more than brand. Smaller suppliers compete on price and application-specific chemistry for niche analyte classes.

Geographic reach is the other axis of competition. North America alone accounts for 33.6% of 2025 revenue, so a supplier absent there is absent from the largest part of the market whatever its position elsewhere; Asia Pacific adds a further 29.5%.

Per-company profiles, financials, share and development history are in the full report and not here.

List of Key Solid Phase Extraction Spe Equipment Market Companies Profiled

14 companies profiled. Company profiles, including financials, product portfolios and recent developments, are part of the full report.

  • Thermo Fisher Scientific(United States)
  • Avantor Performance Materials(United States)
  • Waters Corporation(United States)
  • Agilent Technologies(United States)
  • S*Pure Pte Ltd(Singapore)
  • Merck(Germany)
  • Biotage(Sweden)
  • PerkinElmer(United States)
  • 3M(United States)
  • GL Sciences(Japan)
  • Restek Corporation(United States)
  • Orochem Technologies(United States)
  • Tecan SP(Switzerland)
  • ANPEL Laboratory Technologies(China)
Coverage

Geographic Coverage

5 regions · 30 markets

Every market below is broken out separately in the report.

North America

3
USCanadaMexico

Europe

8
GermanyFranceItalySpainUKNordic CountriesBenelux UnionRest of Europe

Asia Pacific

12
IndiaAustraliaChinaChina (Taiwan)JapanSouth KoreaSoutheast AsiaIndonesiaThailandMalaysiaSingaporeRest of Asia Pacific

Latin America

3
BrazilArgentinaRest of Latin America

Middle East and Africa

4
GCCEgyptSouth AfricaRest of the Middle East & Africa
At a glance

Key Insights

5
Regions covered
Including North America, Europe, Asia Pacific.
14
Companies profiled
Leading companies active in this market.
2025
Base year
Verified base-year data underpins every estimate.
2020–2034
Study period
Historical actuals plus the full forecast horizon.
Parameters

Report Scope

Study parameters & segmentation

This study covers market size and forecasts over the 2020–2034 period, segmentation across 5 axes (Type, Application, Technology, End Use, Automation Level), regional analysis for 5 regions and their constituent countries, a competitive landscape profiling 14 key companies, and the research methodology behind every estimate.

Study period
2020–2034
Base year
2025
Estimated year
2026
Historical period
2020-2024
Forecast period
2026-2034
Growth rate
7.95% CAGR
Unit
USD Million

Segmentation

5 axes + region
By Type
SPE CartridgesSPE DiskWell Plate
By Application
ChemicalFoodBiologicalOthers
By Technology
Reverse PhaseNormal PhaseIon ExchangeMixed Mode
By End Use
Pharmaceutical & Biotechnology CompaniesEnvironmental Testing LaboratoriesFood & Beverage Testing LaboratoriesForensic & Clinical LaboratoriesAcademic & Research Institutes
By Automation Level
Manual SPE SystemsAutomated/Robotic SPE Systems
By Geography
North America: US, Canada, Mexico
Europe: Germany, France, Italy, Spain, UK, Nordic Countries, Benelux Union, Rest of Europe
Asia Pacific: India, Australia, China, China (Taiwan), Japan, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Asia Pacific
Latin America: Brazil, Argentina, Rest of Latin America
Middle East and Africa: GCC, Egypt, South Africa, Rest of the Middle East & Africa
Backed by primary research into key growth drivers, competitive dynamics, and regional demand shifts. Full analysis is available in the sample report.
Scope

Questions This Report Answers

6 questions
01

What is the market size and growth rate, globally and by region?

02

How is the market segmented, and which segments lead?

03

Which regions and countries are covered, and how do they compare?

04

What are the key drivers, restraints, opportunities and challenges?

05

Who are the leading companies operating in this market?

06

What trends are expected to shape the market through the forecast period?

Questions

Frequently Asked Questions

01What is the Solid Phase Extraction Spe Equipment Market projected to reach?

USD 789 Million by 2034, CAGR 7.95%

02What years does this report cover?

Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.

03Which regions are covered?

North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

04Which region accounted for the largest market share?

North America leads with 33.6% of global revenue through 2034.

05Which segment leads the market?

SPE Cartridges is the largest line by Type, at 57.8% of revenue in 2025.

06Who are the key companies profiled?

Thermo Fisher Scientific, Avantor Performance Materials, Waters Corporation, Agilent Technologies, S*Pure Pte Ltd, Merck, Biotage, PerkinElmer, 3M, GL Sciences, Restek Corporation, Orochem Technologies, Tecan SP, ANPEL Laboratory Technologies. Full profiles are part of the paid report.

07Can the segmentation be customized?

Yes. Custom data cuts by geography, segment, or competitor set are available on request.

425+
Dedicated research analysts
1,200+
Reports published
Why CDI

Why choose CDI

Data triangulated across primary and secondary sources
Complimentary analyst call included with every purchase
Custom data cuts and post-purchase support available

Need this report shaped around your question?

The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.

Most licences include 3060 hours of customization at no extra cost. See what each licence includes

Request customization

Additional Companies

Add competitors, suppliers or the peer set you benchmark against to the companies already covered.

Deeper Competitive View

Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.

Extra Segment Splits

Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.

Application Focus

Narrow the analysis to the specific use cases and end users your team actually sells into.

Different Time Frame

Move the base year, or widen the historical and forecast windows the study is built on.

Country-Level Detail

Go below region level into the individual countries that matter to you, rather than the standard geography split.